Navigation Links
Bristol-Myers Squibb to Present at Healthcare Conferences
Date:3/17/2008

NEW YORK, March 17 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) will present at the Cowen and Company 28th Annual Health Care Conference today. Brian Daniels, M.D., senior vice president, Global Development, will make a formal presentation about the company at 1:45 p.m. ET today.

Bristol-Myers Squibb will also present at the Lehman Brothers Global Healthcare Conference on Wednesday, March 19, 2008. John Celentano, senior vice president, Strategy and Productivity Transformation, will make a formal presentation about the company at 11:15 a.m. ET on Wednesday.

Investors and the general public are invited to listen to a live webcast of the presentations at http://www.bms.com/ir. Materials related to the presentations will be available at the same website at the start of each live webcast. An archived edition of each presentation will be available later that day.

Bristol-Myers Squibb is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Bristol-Myers Squibb Announces Dividend
2. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
3. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
4. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
5. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
6. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
7. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
8. Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
9. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
10. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
11. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... MyServer2Go.com made an announcement recently that ... this year for its quality VPS solution, reliable support ... MyServer2Go.com is a professional and targeted website which reviewed ... announcement will help webmasters find the best VPS hosting ... http://www.arvixe.com ) is one of the fastest-growing and most ...
(Date:9/30/2014)... 2014 The accurate measurement of ... cancer risk prediction and to tailor screening protocols ... in Breast Cancer Research (BCR September 2014; 16:439 ... cancer risk: a case-control study of six alternative ... breast density and breast cancer risk. , The ...
(Date:9/30/2014)... to die at home surrounded by loved ones comes ... and how to change the process so that more ... of new research the Frances Payne Bolton School of ... a four-year, $2.06 million grant from the National Institute ... Complex Influences of Aggressiveness of End of Life Cancer ...
(Date:9/30/2014)... published in the October 2014 issue of The ... cancer as easy as a simple blood test. This test, ... detect some cancers earlier than ever before, but it may ... as identify those more likely to develop cancer in the ... so helping to save peoples, lives," said Diana Anderson, a ...
(Date:9/30/2014)... By Dennis Thompson ... -- Every day, people receive medical implants -- artificial ... may not have been rigorously tested before or after their ... studies contend. The studies -- conducted by prominent nonprofit ... Medicine -- lay the blame for inadequate medical device ...
Breaking Medicine News(10 mins):Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 4Health News:CWRU researchers receives $2.06 million to study how patients make end-of-life decisions 2Health News:New blood test determines whether you have or are likely to get cancer 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 4
... of Medicine in St. Louis claim that many children ... Their finding is totally reverse of the claims that ... said that 50 percent of the children who could ... ,"What we found was somewhat surprising," says Richard ...
... Young teenagers believe pregnancy would help them form connections ... boyfriend or creating a family of their own.// ... there are advantages in attaining motherhood early in life. ... the current issue of Pediatrics. ...
... from the University of Maryland School of Medicine, Galantamine, ... disease finds// a new role, in protecting people from ... The basis for further development of a safe and ... including nerve agents that have been used in chemical ...
... was launched in China on 7th August,2006//. ,Cancer is ... of Health department’s report in May. It accounts for ... and lifestyle factors are responsible for 80% of the cancers ... Treatment extends the lives of 60% of the cancer patients ...
... the Oman government's permission to carry out surgeries and ... group's new centre in the Omani capital Muscat. ... green signal to start our operation theatres, Intensive Care ... in the Times of Oman newspaper quoted V.T. Saileswaran ...
... compound derived from red algae to be a potent inhibitor ... warts//. The study has been published in the July ... thickening agent, blocks the Human Papillomavirus (HPV) from sticking to ... compound is a more natural and less expensive way to ...
Cached Medicine News:Health News:ADHD Children Are Being Under-Medicated 2Health News:ADHD Children Are Being Under-Medicated 3Health News:Teens and Pregnancy 2Health News:Teens and Pregnancy 3Health News:Alzheimer's Drug can be Used to Treat Nerve Agent and Pesticide Poisoning 2Health News:Alzheimer's Drug can be Used to Treat Nerve Agent and Pesticide Poisoning 3Health News:New Cancer-Blocking Algae Found 2
(Date:9/30/2014)... SAN DIEGO , Sept. 30, 2014   ... company developing a minimally invasive real-time 3D Cardiac Chamber ... sources that cause and / or sustain complex cardiac ... additional $26.2M financing to continue developing its imaging/mapping system ... portfolio.  The financing will allow Acutus Medical to complete ...
(Date:9/30/2014)... ALTO, Calif. , Sept. 30, 2014 /PRNewswire/ ... investment group focused on supporting promising emerging biotech, ... has been named the Top Angel Investment Group ... Insights as the best performer out of 370 ... included: historical performance, network strength (connections), selection aptitude ...
(Date:9/30/2014)... -- Synapse Biomedical Inc. ( www.synapsebiomedical.com ) announced today ... study of its NeuRx DPS® System for ALS ... FDA enrollment requirement was implanted over a month ... DPS®, which is the only medical device approved ... a humanitarian device that obtained approval at the ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3
... 2007 - Reata,Pharmaceuticals, Inc. today announced the ... Synthetic Triterpenoid programs in,the May 2007 issue ... article, "Triterpenoids and rexinoids as multifunctional,agents for ... researchers,and Reata scientific collaborators from the Dartmouth ...
... least,one-third of the time, the symptoms of bipolar ... children, it can be,difficult to distinguish bipolar symptoms ... issue of the Harvard Mental Health,Letter. , Children, ... cycle of distinct mood episodes of mania and ...
Cached Medicine Technology:Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 2Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 3Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 4Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2
... A lower cost alternative to Equalizers, the ... transfers between two different vessel configurations. With the ... can be quickly and easily adjusted for test ... Ergonomic Design for Unparalleled Comfort Pick ...
... The Equalizer With 384 Well Plate ... the revolutionary features of the original Equalizerexpandable and ... autoclavable components, and in-lab calibration capabilities. In addition, ... tips down to 4.5mm for loading and accessing ...
Packaging: Set includes: Eight-channel pipette (10.8 mm with 0.5-5.0 μl capacity) 25 PrismStrip 96 tips with rack 2 FlexPlates with a holder...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: